BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2761 related articles for article (PubMed ID: 23302119)

  • 41. Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment.
    Caine A; Maltby AE; Parkin CA; Waters JJ; Crolla JA;
    Lancet; 2005 Jul 9-15; 366(9480):123-8. PubMed ID: 16005334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
    Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
    BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalities.
    Hume H; Chasen ST
    Am J Obstet Gynecol; 2015 Oct; 213(4):545.e1-4. PubMed ID: 26070711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].
    Qi QW; Jiang YL; Liu JT; Bian XM; Li Y; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Cai Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
    Hu YL;
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study.
    Bianchi DW; Simpson JL; Jackson LG; Elias S; Holzgreve W; Evans MI; Dukes KA; Sullivan LM; Klinger KW; Bischoff FZ; Hahn S; Johnson KL; Lewis D; Wapner RJ; de la Cruz F
    Prenat Diagn; 2002 Jul; 22(7):609-15. PubMed ID: 12124698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity.
    Huderer-Duric K; Skrablin S; Kuvacic I; Sonicki Z; Rubala D; Suchanek E
    Eur J Obstet Gynecol Reprod Biol; 2000 Jan; 88(1):49-55. PubMed ID: 10659916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: effect of maternal and fetal factors.
    Ashoor G; Poon L; Syngelaki A; Mosimann B; Nicolaides KH
    Fetal Diagn Ther; 2012; 31(4):237-43. PubMed ID: 22572044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prospective evaluation of prenatal maternal serum screening for trisomy 18.
    Yankowitz J; Fulton A; Williamson R; Grant SS; Budelier WT
    Am J Obstet Gynecol; 1998 Mar; 178(3):446-50. PubMed ID: 9539506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
    Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
    Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Performance of different methods of estimating risk screening for chromosomal anomalies].
    Avătăjitei MC; Moscalu M; Martiniuc V; Onofriescu M
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):515-22. PubMed ID: 23077946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18.
    Ashoor G; Syngelaki A; Wagner M; Birdir C; Nicolaides KH
    Am J Obstet Gynecol; 2012 Apr; 206(4):322.e1-5. PubMed ID: 22464073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Rapid detection of the most common chromosomal aneuploidies in the second-trimester amniotic fluid using QF-PCR].
    Švecová I; Burjanivová T; Kršiaková J; Lasabová Z; Biringer K; Kapustová I; Móricová P; Danko J
    Ceska Gynekol; 2013 Aug; 78(4):373-8. PubMed ID: 24040987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Noninvasive prenatal diagnosis of aneuploidy using cell-free nucleic acids in maternal blood: promises and unanswered questions.
    Puszyk WM; Crea F; Old RW
    Prenat Diagn; 2008 Jan; 28(1):1-6. PubMed ID: 18022821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies.
    Canick JA; Palomaki GE; Kloza EM; Lambert-Messerlian GM; Haddow JE
    Prenat Diagn; 2013 Jul; 33(7):667-74. PubMed ID: 23592541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany.
    Soergel P; Pruggmayer M; Schwerdtfeger R; Muhlhaus K; Scharf A
    Fetal Diagn Ther; 2006; 21(3):264-8. PubMed ID: 16601335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of fetal sex chromosome aneuploidy by massively parallel sequencing of maternal plasma DNA: initial experience in a Chinese hospital.
    Yao H; Jiang F; Hu H; Gao Y; Zhu Z; Zhang H; Wang Y; Guo Y; Liu L; Yuan Y; Zhou L; Wang J; Du B; Qu N; Zhang R; Dong Y; Xu H; Chen F; Jiang H; Liu Y; Zhang L; Tian Z; Liu Q; Zhang C; Pan X; Yang S; Zhao L; Wang W; Liang Z
    Ultrasound Obstet Gynecol; 2014 Jul; 44(1):17-24. PubMed ID: 24616044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A multicenter study of fetal chromosomal abnormalities in Chinese women of advanced maternal age.
    Zhu Y; Lu S; Bian X; Wang H; Zhu B; Wang H; Xu Z; Xu L; Yan W; Zeng Y; Chen Z; Tang S; Shen G; Miao Z
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):379-84. PubMed ID: 27343319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of fetal trisomy 9 mosaicism by noninvasive prenatal testing through maternal plasma DNA sequencing.
    Lee CY; Su HJ; Cheng YT; Ku YL; Ngo YG; Chen CM; Ou YC; Lee MC; Shaw SWS
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):594-597. PubMed ID: 30122585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 139.